BiMix Injection Recalled for Lack of Assurance of Sterility
Northern VA Compounders has recalled BiMix Injection due to lack of assurance of sterility. Patients using affected lots should consult their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a compounded injectable medication for lack of assurance of sterility. Sterility failures in injectable drugs pose a significant risk of serious infection. No illnesses or injuries have been reported in the source material, placing this in the High category for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Northern VA Compounders PLLC has recalled BiMix Injection (Papaverine HCl/Phentolamine Mesylate) 30mg/0.5mg/mL due to lack of assurance of sterility in the compounded injectable product. The recall affects 4 vials distributed nationwide, lot number 12062022@3, with expiration date 1/20/2023.
Lack of assurance of sterility in injectable medications poses a risk of microbial contamination, which could lead to serious infections if the product is administered. The product was compounded by Akina Pharmacy in Sterling, Virginia, and manufactured by Northern VA Compounders PLLC.
Patients who have received this medication or possess vials from the affected lot should immediately contact their healthcare provider or pharmacist. Do not use vials from lot 12062022@3. Healthcare providers and patients should report any adverse events related to the use of this product to the FDA.
The recalled product
- Product
- BiMix Injection (Papaverine HCl/Phentolamine Mesylate) 30mg/0.5mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.
- Manufacturer
- Northern VA Compounders PLLC
- Category
- Drug — Compounded Injectable
- Hazard
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 12062022@3
- Exp 1/20/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 25 recalled by Northern VA Compounders PLLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Northern VA Compounders PLLC
See all →- HighQuadMix Plus Injectable Medication Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-01-18
- HighTriMix Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-01-18
- HighTriMix Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-01-18
- HighTriMix Plus 002 Injectable Medication Recalled for Sterility Concerns
FDA (Drugs) · 2023-01-18
- HighCompounded Injectable Medication Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-01-18
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29